Analyst Price Target is $122.67
▲ +24.02% Upside Potential
This price target is based on 21 analysts offering 12 month price targets for Merck & Co., Inc. in the last 3 months. The average price target is $122.67, with a high forecast of $155.00 and a low forecast of $104.00. The average price target represents a 24.02% upside from the last price of $98.91.
Current Consensus is
Moderate Buy
The current consensus among 21 polled investment analysts is to moderate buy stock in Merck & Co., Inc.. This Moderate Buy consensus rating has held steady for over two years.
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Read More